Global Orlistat Market Research Report 2022

Publisher Name :
Date: 04-Jul-2022
No. of pages: 97
Inquire Before Buying

Due to the COVID-19 pandemic, the global Orlistat market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Orlistat market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Orlistat landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

120mg Orlistat accounting for % of the Orlistat global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Weight-reducing Aid segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Orlistat include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Orlistat in 2021.

This report focuses on Orlistat volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Orlistat market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Orlistat Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 120mg Orlistat

- 60mg Orlistat

Segment by Application

- Weight-reducing Aid

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Roche

- GSK group

- Teva

- Sandoz(Novartis)

- STADA-VN J.V.Co., Ltd

- Hexal AG

- National Company for Pharmaceutical Industry

- Lunan Pharmaceutical Group Corporation

- ZEIN pharmaceutical

- HISUN

- Taj Pharmaceuticals Ltd

- Kabir Life Sciences & Research

- DM Pharma

- China Zhongshan Pharm

Global Orlistat Market Research Report 2022

Table of Contents
1 Orlistat Market Overview
1.1 Product Overview and Scope of Orlistat
1.2 Orlistat Segment by Type
1.2.1 Global Orlistat Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 120mg Orlistat
1.2.3 60mg Orlistat
1.3 Orlistat Segment by Application
1.3.1 Global Orlistat Sales Comparison by Application: (2022-2028)
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Global Orlistat Market Size Estimates and Forecasts
1.4.1 Global Orlistat Revenue 2017-2028
1.4.2 Global Orlistat Sales 2017-2028
1.4.3 Orlistat Market Size by Region: 2017 Versus 2021 Versus 2028
2 Orlistat Market Competition by Manufacturers
2.1 Global Orlistat Sales Market Share by Manufacturers (2017-2022)
2.2 Global Orlistat Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Orlistat Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Orlistat Manufacturing Sites, Area Served, Product Type
2.5 Orlistat Market Competitive Situation and Trends
2.5.1 Orlistat Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Orlistat Players Market Share by Revenue
2.5.3 Global Orlistat Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orlistat Retrospective Market Scenario by Region
3.1 Global Orlistat Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Orlistat Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Orlistat Market Facts & Figures by Country
3.3.1 North America Orlistat Sales by Country
3.3.2 North America Orlistat Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Orlistat Market Facts & Figures by Country
3.4.1 Europe Orlistat Sales by Country
3.4.2 Europe Orlistat Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Orlistat Market Facts & Figures by Region
3.5.1 Asia Pacific Orlistat Sales by Region
3.5.2 Asia Pacific Orlistat Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Orlistat Market Facts & Figures by Country
3.6.1 Latin America Orlistat Sales by Country
3.6.2 Latin America Orlistat Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Orlistat Market Facts & Figures by Country
3.7.1 Middle East and Africa Orlistat Sales by Country
3.7.2 Middle East and Africa Orlistat Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Orlistat Historic Market Analysis by Type
4.1 Global Orlistat Sales Market Share by Type (2017-2022)
4.2 Global Orlistat Revenue Market Share by Type (2017-2022)
4.3 Global Orlistat Price by Type (2017-2022)
5 Global Orlistat Historic Market Analysis by Application
5.1 Global Orlistat Sales Market Share by Application (2017-2022)
5.2 Global Orlistat Revenue Market Share by Application (2017-2022)
5.3 Global Orlistat Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Orlistat Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 GSK group
6.2.1 GSK group Corporation Information
6.2.2 GSK group Description and Business Overview
6.2.3 GSK group Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK group Orlistat Product Portfolio
6.2.5 GSK group Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Teva Orlistat Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz(Novartis)
6.4.1 Sandoz(Novartis) Corporation Information
6.4.2 Sandoz(Novartis) Description and Business Overview
6.4.3 Sandoz(Novartis) Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sandoz(Novartis) Orlistat Product Portfolio
6.4.5 Sandoz(Novartis) Recent Developments/Updates
6.5 STADA-VN J.V.Co., Ltd
6.5.1 STADA-VN J.V.Co., Ltd Corporation Information
6.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
6.5.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.5.4 STADA-VN J.V.Co., Ltd Orlistat Product Portfolio
6.5.5 STADA-VN J.V.Co., Ltd Recent Developments/Updates
6.6 Hexal AG
6.6.1 Hexal AG Corporation Information
6.6.2 Hexal AG Description and Business Overview
6.6.3 Hexal AG Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hexal AG Orlistat Product Portfolio
6.6.5 Hexal AG Recent Developments/Updates
6.7 National Company for Pharmaceutical Industry
6.6.1 National Company for Pharmaceutical Industry Corporation Information
6.6.2 National Company for Pharmaceutical Industry Description and Business Overview
6.6.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.4.4 National Company for Pharmaceutical Industry Orlistat Product Portfolio
6.7.5 National Company for Pharmaceutical Industry Recent Developments/Updates
6.8 Lunan Pharmaceutical Group Corporation
6.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
6.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.8.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio
6.8.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.9 ZEIN pharmaceutical
6.9.1 ZEIN pharmaceutical Corporation Information
6.9.2 ZEIN pharmaceutical Description and Business Overview
6.9.3 ZEIN pharmaceutical Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.9.4 ZEIN pharmaceutical Orlistat Product Portfolio
6.9.5 ZEIN pharmaceutical Recent Developments/Updates
6.10 HISUN
6.10.1 HISUN Corporation Information
6.10.2 HISUN Description and Business Overview
6.10.3 HISUN Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.10.4 HISUN Orlistat Product Portfolio
6.10.5 HISUN Recent Developments/Updates
6.11 Taj Pharmaceuticals Ltd
6.11.1 Taj Pharmaceuticals Ltd Corporation Information
6.11.2 Taj Pharmaceuticals Ltd Orlistat Description and Business Overview
6.11.3 Taj Pharmaceuticals Ltd Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Taj Pharmaceuticals Ltd Orlistat Product Portfolio
6.11.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
6.12 Kabir Life Sciences & Research
6.12.1 Kabir Life Sciences & Research Corporation Information
6.12.2 Kabir Life Sciences & Research Orlistat Description and Business Overview
6.12.3 Kabir Life Sciences & Research Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Kabir Life Sciences & Research Orlistat Product Portfolio
6.12.5 Kabir Life Sciences & Research Recent Developments/Updates
6.13 DM Pharma
6.13.1 DM Pharma Corporation Information
6.13.2 DM Pharma Orlistat Description and Business Overview
6.13.3 DM Pharma Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.13.4 DM Pharma Orlistat Product Portfolio
6.13.5 DM Pharma Recent Developments/Updates
6.14 China Zhongshan Pharm
6.14.1 China Zhongshan Pharm Corporation Information
6.14.2 China Zhongshan Pharm Orlistat Description and Business Overview
6.14.3 China Zhongshan Pharm Orlistat Sales, Revenue and Gross Margin (2017-2022)
6.14.4 China Zhongshan Pharm Orlistat Product Portfolio
6.14.5 China Zhongshan Pharm Recent Developments/Updates
7 Orlistat Manufacturing Cost Analysis
7.1 Orlistat Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Orlistat
7.4 Orlistat Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Orlistat Distributors List
8.3 Orlistat Customers
9 Orlistat Market Dynamics
9.1 Orlistat Industry Trends
9.2 Orlistat Market Drivers
9.3 Orlistat Market Challenges
9.4 Orlistat Market Restraints
10 Global Market Forecast
10.1 Orlistat Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Orlistat by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Orlistat by Type (2023-2028)
10.2 Orlistat Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Orlistat by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Orlistat by Application (2023-2028)
10.3 Orlistat Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Orlistat by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Orlistat by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Orlistat Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Orlistat Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Orlistat Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Orlistat Market Competitive Situation by Manufacturers in 2021
Table 5. Global Orlistat Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Orlistat Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Orlistat Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Orlistat Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Orlistat Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Orlistat Manufacturing Sites and Area Served
Table 11. Manufacturers Orlistat Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Orlistat by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orlistat as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Orlistat Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Orlistat Sales Market Share by Region (2017-2022)
Table 17. Global Orlistat Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Orlistat Revenue Market Share by Region (2017-2022)
Table 19. North America Orlistat Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Orlistat Sales Market Share by Country (2017-2022)
Table 21. North America Orlistat Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Orlistat Revenue Market Share by Country (2017-2022)
Table 23. Europe Orlistat Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Orlistat Sales Market Share by Country (2017-2022)
Table 25. Europe Orlistat Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Orlistat Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Orlistat Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Orlistat Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Orlistat Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Orlistat Revenue Market Share by Region (2017-2022)
Table 31. Latin America Orlistat Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Orlistat Sales Market Share by Country (2017-2022)
Table 33. Latin America Orlistat Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Orlistat Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Orlistat Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Orlistat Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Orlistat Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Orlistat Revenue Market Share by Country (2017-2022)
Table 39. Global Orlistat Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Orlistat Sales Market Share by Type (2017-2022)
Table 41. Global Orlistat Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Orlistat Revenue Share by Type (2017-2022)
Table 43. Global Orlistat Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Orlistat Sales (K Pcs) by Application (2017-2022)
Table 45. Global Orlistat Sales Market Share by Application (2017-2022)
Table 46. Global Orlistat Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Orlistat Revenue Share by Application (2017-2022)
Table 48. Global Orlistat Price by Application (2017-2022) & (USD/Pcs)
Table 49. Roche Corporation Information
Table 50. Roche Description and Business Overview
Table 51. Roche Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Roche Orlistat Product
Table 53. Roche Recent Developments/Updates
Table 54. GSK group Corporation Information
Table 55. GSK group Description and Business Overview
Table 56. GSK group Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. GSK group Orlistat Product
Table 58. GSK group Recent Developments/Updates
Table 59. Teva Corporation Information
Table 60. Teva Description and Business Overview
Table 61. Teva Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Teva Orlistat Product
Table 63. Teva Recent Developments/Updates
Table 64. Sandoz(Novartis) Corporation Information
Table 65. Sandoz(Novartis) Description and Business Overview
Table 66. Sandoz(Novartis) Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Sandoz(Novartis) Orlistat Product
Table 68. Sandoz(Novartis) Recent Developments/Updates
Table 69. STADA-VN J.V.Co., Ltd Corporation Information
Table 70. STADA-VN J.V.Co., Ltd Description and Business Overview
Table 71. STADA-VN J.V.Co., Ltd Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. STADA-VN J.V.Co., Ltd Orlistat Product
Table 73. STADA-VN J.V.Co., Ltd Recent Developments/Updates
Table 74. Hexal AG Corporation Information
Table 75. Hexal AG Description and Business Overview
Table 76. Hexal AG Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Hexal AG Orlistat Product
Table 78. Hexal AG Recent Developments/Updates
Table 79. National Company for Pharmaceutical Industry Corporation Information
Table 80. National Company for Pharmaceutical Industry Description and Business Overview
Table 81. National Company for Pharmaceutical Industry Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. National Company for Pharmaceutical Industry Orlistat Product
Table 83. National Company for Pharmaceutical Industry Recent Developments/Updates
Table 84. Lunan Pharmaceutical Group Corporation Corporation Information
Table 85. Lunan Pharmaceutical Group Corporation Description and Business Overview
Table 86. Lunan Pharmaceutical Group Corporation Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Lunan Pharmaceutical Group Corporation Orlistat Product
Table 88. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
Table 89. ZEIN pharmaceutical Corporation Information
Table 90. ZEIN pharmaceutical Description and Business Overview
Table 91. ZEIN pharmaceutical Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. ZEIN pharmaceutical Orlistat Product
Table 93. ZEIN pharmaceutical Recent Developments/Updates
Table 94. HISUN Corporation Information
Table 95. HISUN Description and Business Overview
Table 96. HISUN Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. HISUN Orlistat Product
Table 98. HISUN Recent Developments/Updates
Table 99. Taj Pharmaceuticals Ltd Corporation Information
Table 100. Taj Pharmaceuticals Ltd Description and Business Overview
Table 101. Taj Pharmaceuticals Ltd Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Taj Pharmaceuticals Ltd Orlistat Product
Table 103. Taj Pharmaceuticals Ltd Recent Developments/Updates
Table 104. Kabir Life Sciences & Research Corporation Information
Table 105. Kabir Life Sciences & Research Description and Business Overview
Table 106. Kabir Life Sciences & Research Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Kabir Life Sciences & Research Orlistat Product
Table 108. Kabir Life Sciences & Research Recent Developments/Updates
Table 109. DM Pharma Corporation Information
Table 110. DM Pharma Description and Business Overview
Table 111. DM Pharma Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. DM Pharma Orlistat Product
Table 113. DM Pharma Recent Developments/Updates
Table 114. China Zhongshan Pharm Corporation Information
Table 115. China Zhongshan Pharm Description and Business Overview
Table 116. China Zhongshan Pharm Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. China Zhongshan Pharm Orlistat Product
Table 118. China Zhongshan Pharm Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Orlistat Distributors List
Table 122. Orlistat Customers List
Table 123. Orlistat Market Trends
Table 124. Orlistat Market Drivers
Table 125. Orlistat Market Challenges
Table 126. Orlistat Market Restraints
Table 127. Global Orlistat Sales Forecast by Type (2023-2028) & (K Pcs)
Table 128. Global Orlistat Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Orlistat Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Orlistat Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Orlistat Sales Forecast by Application (2023-2028) & (K Pcs)
Table 132. Global Orlistat Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Orlistat Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Orlistat Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Orlistat Sales Forecast by Region (2023-2028) & (K Pcs)
Table 136. Global Orlistat Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Orlistat Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Orlistat Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Orlistat
Figure 2. Global Orlistat Market Share by Type in 2021 & 2028
Figure 3. 120mg Orlistat Product Picture
Figure 4. 60mg Orlistat Product Picture
Figure 5. Global Orlistat Market Share by Application in 2021 & 2028
Figure 6. Weight-reducing Aid
Figure 7. Other
Figure 8. Global Orlistat Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Orlistat Market Size (2017-2028) & (US$ Million)
Figure 10. Global Orlistat Sales (2017-2028) & (K Pcs)
Figure 11. Orlistat Sales Share by Manufacturers in 2021
Figure 12. Global Orlistat Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Orlistat Players: Market Share by Revenue in 2021
Figure 14. Orlistat Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Orlistat Sales Market Share by Region (2017-2022)
Figure 16. Global Orlistat Sales Market Share by Region in 2021
Figure 17. Global Orlistat Revenue Market Share by Region (2017-2022)
Figure 18. Global Orlistat Revenue Market Share by Region in 2021
Figure 19. U.S. Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Taiwan Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Philippines Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Vietnam Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. U.A.E Orlistat Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Orlistat by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Orlistat
Figure 45. Manufacturing Process Analysis of Orlistat
Figure 46. Orlistat Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
  • Global Market for Anti-obesity Drugs
    Published: 28-Nov-2023        Price: US 3500 Onwards        Pages: 67
    Report Scope: The report's scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players' profiles, marketed products, ......
  • Anti-Obesity Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 87
    This study focuses on China's Anti-Obesity Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. ......
  • Anti-Obesity Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Anti-Obesity Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions ......
  • Anti-Obesity Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 211
    China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Global Orlistat Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Orlistat market: According to our latest research, the global Orlistat market looks promising in the next 5 years. As of 2022, the global Orlistat market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby re......
  • Global Weight Loss Pills Market Research Report 2023
    Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Weight Loss Pills market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GNC - HUM - Amway - Abott Laboratories - Avon - Atkins Nutritional - Creative Bioscience - Glanbia - Herbalife - Healthv......
  • Global Orlistat Market Insights, Forecast to 2028
    Published: 28-Aug-2023        Price: US 4900 Onwards        Pages: 111
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Orlistat is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market......
  • Global Obesity Market (2023 Edition) - Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By Gender, By Region, By Country: Drivers, Trends and Forecast to 2029
    Published: 01-Aug-2023        Price: US 2450 Onwards        Pages: 270
    Executive Summary Azoth Analytics has released a research report titled "Global Obesity Market (2023 Edition)" which provides a complete analysis of the Global Obesity Industry By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Other Drugs), Age Group (0-18 years, 19-39 years, 40-59 years, Above 60 years), Gender (Male, Female) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029. The research r......
  • Global Orlistat Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jul-2023        Price: US 3260 Onwards        Pages: 100
    Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. The Orlistat market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteris......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs